361 Capital’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-67,660
Closed -$1.18M 394
2019
Q4
$1.18M Buy
+67,660
New +$1.15M 0.33% 185
2019
Q3
Sell
-135,224
Closed -$2.55M 380
2019
Q2
$2.55M Sell
135,224
-9,529
-7% -$163K 0.45% 111
2019
Q1
$2.54M Sell
144,753
-13,890
-9% -$254K 0.44% 119
2018
Q4
$2.76M Buy
158,643
+32,279
+26% +$483K 0.56% 13
2018
Q3
$1.79M Buy
+126,364
New +$1.48M 0.39% 100

Other funds holding VCEL

361 Capital's VCEL Position: Q1 2020 in Review

361 Capital sold out of Vericel Corp (VCEL) in Q1 2020, closing a stake of 67,660 shares — an estimated $1.18M sold.

361 Capital first reported a position in VCEL in Q3 2018 and held it in 5 quarters. The position peaked at $2.76M in Q4 2018. 133 funds tracked by Wall St. Rank hold VCEL as of Q1 2020.

  • 361 Capital reported no remaining Vericel Corp position as of Q1 2020 after selling out during the quarter.
  • 361 Capital sold 67,660 Vericel Corp shares in Q1 2020, an estimated $1.18M.
  • 361 Capital first reported a position in Vericel Corp in Q3 2018 and held it in 5 quarters.
  • 361 Capital's Vericel Corp position peaked at $2.76M in Q4 2018.
  • 133 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2020.

Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.